Plasma Proteomic Analysis Reveals the Potential Role of Lectin and Alternative Complement Pathways in IgA Vasculitis Pathogenesis

Background: IgA vasculitis (IgAV) is the most common form of childhood vasculitis. A better understanding of its pathophysiology is required to identify new potential biomarkers and treatment targets. Objective: to assess the underlying molecular mechanisms in the pathogenesis of IgAV using an untargeted proteomics approach. Methods: Thirty-seven IgAV patients and five healthy controls were enrolled. Plasma samples were collected on the day of diagnosis before any treatment was initiated. We used nano-liquid chromatography–tandem mass spectrometry (nLC–MS/MS) to investigate the alterations in plasma proteomic profiles. For the bioinformatics analyses, databases including Uniprot, PANTHER, KEGG, Reactome, Cytoscape, and IntAct were used. Results: Among the 418 proteins identified in the nLC–MS/MS analysis, 20 had significantly different expressions in IgAV patients. Among them, 15 were upregulated and 5 were downregulated. According to the KEGG pathway and function classification analysis, complement and coagulation cascades were the most enriched pathways. GO analyses showed that the differentially expressed proteins were mainly involved in defense/immunity proteins and the metabolite interconversion enzyme family. We also investigated molecular interactions in the identified 20 proteins of IgAV patients. We extracted 493 interactions from the IntAct database for the 20 proteins and used Cytoscape for the network analyses. Conclusion: Our results clearly suggest the role of the lectin and alternate complement pathways in IgAV. The proteins defined in the pathways of cell adhesion may serve as biomarkers. Further functional studies may lead the way to better understanding of the disease and new therapeutic options for IgAV treatment.

[1]  M. Seelen,et al.  Lectin and alternative complement pathway activation in cutaneous manifestations of IgA-vasculitis: A new target for therapy? , 2022, Molecular immunology.

[2]  Bangmao Wang,et al.  The Potential Role of REG Family Proteins in Inflammatory and Inflammation-Associated Diseases of the Gastrointestinal Tract , 2021, International journal of molecular sciences.

[3]  Dipal M. Patel,et al.  IgA vasculitis complicated by acute kidney failure with thrombotic microangiopathy: successful use of eculizumab , 2021, Journal of Nephrology.

[4]  Youhe Gao,et al.  Proteomic analysis of urine reveals biomarkers for the diagnosis and phenotyping of abdominal-type Henoch-Schonlein purpura , 2021, Translational pediatrics.

[5]  S. Ozen,et al.  Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis. , 2020, Seminars in arthritis and rheumatism.

[6]  J. Barratt,et al.  Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis , 2020, Nephron.

[7]  P. Zhou,et al.  An Integrated Transcriptomic and Proteomic Analysis Identifies Significant Novel Pathways for Henoch-Schönlein Purpura Nephritis Progression , 2020, BioMed research international.

[8]  B. Julian,et al.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy , 2019, Front. Immunol..

[9]  Deqing Wang,et al.  [Evaluation and Comparison of Thromboelastography and Conventional Coagulation Tests for Blood Coagulation Function in Children with Henoch-Schönlein Purpura]. , 2019, Zhongguo shi yan xue ye xue za zhi.

[10]  K. Masutani,et al.  Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy , 2018, Clinical and Experimental Nephrology.

[11]  J. Doré,et al.  Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. , 2017, Gastroenterology.

[12]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[13]  A. Jamin,et al.  New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). , 2017, Autoimmunity reviews.

[14]  Lin Sun,et al.  Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis children , 2017, Oncotarget.

[15]  F. Berven,et al.  Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy , 2017, Clinical Proteomics.

[16]  Yong-Beom Park,et al.  Serum anti‐lysozyme is associated with disease activity of Behçet's disease , 2017, International journal of rheumatic diseases.

[17]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[18]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[19]  Rohit Sharma.  Revised International Chapel Hill Consensus Conference nomenclature of vasculitides , 2016, Radiopaedia.org.

[20]  Chunhua Yu,et al.  Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis , 2015, PloS one.

[21]  B. Julian,et al.  New Insights into the Pathogenesis of IgA Nephropathy , 2015, Kidney Diseases.

[22]  B. Julian,et al.  Current Understanding of the Role of Complement in IgA Nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[23]  J. Lünemann,et al.  Fc Glycan-Modulated Immunoglobulin G Effector Functions , 2014, Journal of Clinical Immunology.

[24]  Tao Chen,et al.  Increased serum levels of soluble vascular endothelial-cadherin in patients with systemic vasculitis , 2014, Rheumatology International.

[25]  G. Remuzzi,et al.  Overview of Complement Activation and Regulation , 2013, Seminars in nephrology.

[26]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[27]  T. Yoo,et al.  Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy , 2012, PloS one.

[28]  M. Mubarak.  Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford Classification patient cohort. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[30]  S. Bellur,et al.  Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  M. Huber-Lang,et al.  New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System , 2010, Molecular medicine.

[32]  I. Dursun,et al.  Circulating endothelial microparticles in children with Henoch–Schönlein purpura; preliminary results , 2011, Rheumatology International.

[33]  A. Bakkaloğlu,et al.  EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.

[34]  M. Habibagahi,et al.  Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Behçet’s disease , 2010, Modern rheumatology.

[35]  A. Krarup,et al.  The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. , 2008, Biochimica et biophysica acta.

[36]  G. Sesti,et al.  Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic Subjects , 2008, Diabetes Care.

[37]  R. Dwek,et al.  Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[38]  M. Rastaldi,et al.  Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. , 2006, Journal of the American Society of Nephrology : JASN.

[39]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[40]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[41]  Aled Clayton,et al.  Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.

[42]  M. Tremblay,et al.  Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[44]  J. Feehally,et al.  Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  A. Lupo,et al.  Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  L. Matturri,et al.  Renal allograft rejection: immunohistochemistry of inflammatory cellular subsets and vascular lesions. , 1986, Basic and applied histochemistry.

[47]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .